High-Risk Drug Monitoring · Forest Gate

High-Risk Drug Monitoring in Forest Gate.

Systematic monitoring of DOACs, lithium, methotrexate, amiodarone and other high-risk drugs — to ICB-specified intervals and audit-ready evidence. Delivered to Forest Gate PCNs and GP practices from the BCS Chiswick (West London) hub — with paired cover from our Halifax (West Yorkshire) hub. BCS is the only UK provider operating this dual-hub clinical pharmacy model.

Dual-hub delivery

The only UK provider with a Yorkshire + London hub.

Every high-risk drug monitoring placement in Forest Gate is mobilised from one of our two clinical hubs — Chiswick (West London) as the lead and Halifax (West Yorkshire) as paired cover. The dual-hub model is unique to BCS: no other clinical pharmacy provider in the UK runs Northern and Southern hubs with shared SOPs, shared supervision and same-week cross-cover. That is what guarantees continuity of high-risk drug monitoring for a Forest Gate PCN through sickness, leave and turnover.

  • Lead delivery from the BCS Chiswick (West London) hub
  • Paired cover from BCS Halifax (West Yorkshire) — same SOPs, same supervision
  • Same-week sickness, leave and maternity cover guaranteed
  • ARRS-compliant, GPhC-registered, IP-qualified workforce
  • One SLA, one report, one escalation point

Forest Gate · local context

Forest Gate PCNs sit within the relevant London ICB (NW, NC, NE, SE or SW London).

Forest Gate PCNs balance high care home density with a young, transient working-age population — SMRs and contraception/travel work share the BCS pharmacist diary.

What you get

What high-risk drug monitoring in Forest Gate actually looks like.

  • DOAC review and renal function tracking
  • Lithium, methotrexate, amiodarone monitoring
  • Recall and chase workflow
  • Missed monitoring escalation
  • Closed-loop audit evidence

Forest Gate · what good looks like

Typical first-year markers.

4–6 wks
Mobilisation in Forest Gate
2 hubs
Halifax + Chiswick — unique to BCS
100%
Supervision evidenced for audit
Monthly
QA-checked outcomes report

Why Forest Gate PCNs choose BCS for high-risk drug monitoring.

Solo recruitment for high-risk drug monitoring in Forest Gate leaves a network exposed to sickness, maternity and retention risk, and rarely meets the supervision standard ICBs now ask for. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, and continuity is guaranteed by the Chiswick (West London)/Halifax (West Yorkshire) dual-hub.

Whether you are a single Forest Gate PCN starting your first high-risk drug monitoring programme, or a federation coordinating high-risk drug monitoring across multiple London networks, the BCS managed model scales without changing your contract.

Frequently asked questions — High-Risk Drug Monitoring in Forest Gate.

What proportion of patients are typically overdue?+

First sweeps typically find 15-25% of high-risk drug patients overdue for monitoring.

Does BCS already deliver high-risk drug monitoring in Forest Gate?+

BCS supports PCNs and GP practices across London from our Chiswick (West London) hub with paired cover from Halifax (West Yorkshire), and is actively delivering or available to mobilise high-risk drug monitoring in Forest Gate. Get in touch and we'll confirm current capacity.

What makes the dual-hub model different?+

BCS is the only UK clinical pharmacy provider running both a Northern (Halifax) and Southern (Chiswick) hub. That means same-week cross-cover, one SOP set across the country, and no service gap when staff are off — something single-hub or single-region providers cannot match.

How quickly can BCS mobilise high-risk drug monitoring in Forest Gate?+

In most cases BCS mobilises high-risk drug monitoring for a Forest Gate PCN within 4 to 6 weeks of contract sign-off, with remote prescribing back-up available from the hub sooner if needed.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call